Sven Gohla
- Pharmaceutical Science top 0.05%
- Molecular Biology top 10%
- Food Science top 0.5%
- Dermatology top 0.5%
- Biomaterials top 5%
- Co-authors
- Rainer MüllerMonika Schäfer‐KortingCornelia M. KeckAndreas F. ThünemannAnja GyslerRanjita ShegokarKhalil MitriCecilia Anselmi
- Topics
- Advancements in Transdermal Drug Delivery (10 papers)Lipid Membrane Structure and Behavior (5 papers)Bee Products Chemical Analysis (5 papers)
In The Last Decade
Sven Gohla
21 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Pharmaceutical Science 2.2k
- Molecular Biology 1.0k
- Food Science 953
- Dermatology 531
- Biomaterials 374
Countries citing papers authored by Sven Gohla
This map shows the geographic impact of Sven Gohla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Gohla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Gohla more than expected).
Fields of papers citing papers by Sven Gohla
This network shows the impact of papers produced by Sven Gohla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Gohla. The network helps show where Sven Gohla may publish in the future.
Co-authorship network of co-authors of Sven Gohla
This figure shows the co-authorship network connecting the top 25 collaborators of Sven Gohla. A scholar is included among the top collaborators of Sven Gohla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Gohla. Sven Gohla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 37 | |
| 3 | 125 | |
| 4 | 319 | |
| 5 | State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular deliverybreakdown → | 537 |
| 6 | 7 | |
| 7 | 52 | |
| 8 | 108 | |
| 9 | 114 | |
| 10 | Scaling up feasibility of the production of solid lipid nanoparticles (SLN). | 55 |
| 11 | 481 | |
| 12 | 414 | |
| 13 | 421 | |
| 14 | 134 | |
| 15 | 168 | |
| 16 | 169 | |
| 17 | 8 | |
| 18 | 8 | |
| 19 | 1 | |
| 20 | 10 |
About Sven Gohla
Sven Gohla is a scholar working on Pharmaceutical Science, Insect Science and Food Science, having authored 21 papers that have together received 3.2k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (10 papers), Lipid Membrane Structure and Behavior (5 papers) and Bee Products Chemical Analysis (5 papers). The work is most often cited by research in Pharmaceutical Science (2.2k citations), Dermatology (531 citations) and Food Science (953 citations). Sven Gohla has collaborated with scholars based in Germany, Italy and Malaysia. Frequent co-authors include Rainer Müller, Monika Schäfer‐Korting, Cornelia M. Keck, Andreas F. Thünemann, Anja Gysler, Ranjita Shegokar, Khalil Mitri, Cecilia Anselmi, Aaron Dingler and Karsten Mäder. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.